# Utility of Exparel Based ESP Blocks in Elective Posterior Spine Fusion

> **NCT06107660** · PHASE4 · UNKNOWN · sponsor: **Hartford Hospital** · enrollment: 100 (estimated)

## Conditions studied

- Spine Fusion
- Anesthesia, Local

## Interventions

- **DRUG:** Liposomal bupivacaine
- **DRUG:** Bupivacaine

## Key facts

- **NCT ID:** NCT06107660
- **Lead sponsor:** Hartford Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-12
- **Primary completion:** 2025-06
- **Final completion:** 2025-12
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2023-10-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06107660

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06107660, "Utility of Exparel Based ESP Blocks in Elective Posterior Spine Fusion". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT06107660. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*